of the bladder that is high-grade, whether it is primary or recurrent. This high-risk group includes patients with high-grade papillary stage Ta or T1 tumors and any patient with carcinoma in situ ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback